Evidence map›Paper›PMID 40721003›Full record

ArticleDevelopmental biology2025

PRDM13 is required for specification of PAX2 lineage inhibitory neurons in the developing cerebellum.

Z Zack Ma, Michael A Hale, Bishakha Mona, Ana Uruena, Jane E Johnson

Abstract read
In one paragraph

Article in Developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Z Zack MaDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX, United States; Current, Department of Pharmacology, Vanderbilt University, Nashville, TN, United States.
Michael A HaleDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX, United States.
Bishakha MonaDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX, United States.
Ana UruenaDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX, United States.
Jane E JohnsonDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX, United States; Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, United States. Electronic address: jane.johnson@utsouthwestern.edu.

Funding

Transcription Factor Control of Neuronal DiversityR37HD091856 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI Jane E Johnson · 2017 to 2026
$4.7M
NICHD NIH HHS R37 HD091856
6 · The paper itself

Abstract

Shared genetic developmental programs in which specific transcription factors affect similar cell fate decisions in distinct tissues are common. In the developing dorsal neural tube and cerebellum, PTF1A is essential for specification of GABAergic inhibitory neurons and suppression of alternative glutamatergic excitatory neuronal fates. Previous studies in the mouse dorsal neural tube identified the transcriptional repressor PRDM13 as a transcriptional target of PTF1A that functions to suppress the alternate cell fates to ensure precision in neuronal cell identity. The presence of PRDM13 in PTF1A + cerebellar progenitors suggests a similar role for PRDM13 in cerebellar neuronal specification. Cerebellar agenesis in humans with missense mutations in PRDM13, and perturbations in cerebellar development in Prdm13 mutant mice and zebrafish, confirm PRDM13 requirement in this tissue. Here we add to these findings showing additional mutant alleles in mouse Prdm13 phenocopy the perturbation in cerebellar cell fates seen with the absence of PTF1A, including loss of PAX2+ interneuron and Purkinje cell inhibitory neuronal lineages, increases in TLX3+ excitatory neuronal lineages, increased apoptosis, and reduced cerebellar size. Additional defects are seen in the placement of TBR1+ cerebellar cells. Thus, using Prdm13 mutant mice, we support conclusions that PRDM13 functions to specify balanced numbers of inhibitory and excitatory neuronal progenitors in the developing cerebellum.

Indexed as

CerebellumHistone-Lysine N-MethyltransferasePAX2 Transcription FactorTranscription FactorsAnimalsCell DifferentiationGene Expression Regulation, DevelopmentalMiceNeuronsPurkinje CellsZebrafishZebrafish ProteinsHistone-Lysine N-MethyltransferasePax2 protein, mousePAX2 Transcription FactorPrdm13 protein, mouseTranscription FactorsZebrafish ProteinsCell fate specificationCerebellar developmentPRDM13PTF1A

Identifiers

PMID40721003
PMCPMC12535285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.